Related Experiment Video
Updated: Jun 6, 2025

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
Published on: June 2, 2020
Selenoprotein P is a target for regulating extracellular vesicle biogenesis and secretion from activated microglia
Victor Bodart-Santos1, Zhi Ruan1, Bridgette C Melvin1
1Department of Neuroscience, Mayo Clinic Florida, Jacksonville, FL 32224, USA.
Abstract:
Microglia, brain innate immune cells, participate in the spread of inflammatory signals and aggregated proteins through secretion of extracellular vesicles (EVs). Selenoprotein P (Sepp1) is a potential regulator of microglial EV secretion. Here, we investigate the effect of Sepp1 silencing on microglial transcriptomics to elucidate the Sepp1 regulatory mechanism of EV secretion and validate this effect in APPNL-G-F knockin mice. Silencing of Sepp1 significantly reduces EV secretion and CD63 loading to EVs from BV-2 microglia, as determined by single-vesicle flow cytometry and super-resolution microscopy. Sepp1 deficiency downregulates EV biogenesis machinery, accompanied by increased lysosomal activity and lipid metabolism. Silencing of Sepp1 in astrocytes but not neurons suppresses EV secretion in vitro. Finally, Sepp1 silencing reduces EV secretion from activated neurodegenerative microglia associated with amyloid plaques in APPNL-G-F mouse brains in vivo. Sepp1 is thus an emerging therapeutic target for ameliorating microglia-mediated disease spread through EV secretion in neurodegenerative disorders.
Insights
Selenoprotein P (Sepp1) regulates extracellular vesicle (EV) secretion by microglia, key brain immune cells. Reducing Sepp1 lowers EV release and CD63 loading, offering a therapeutic target for neurodegenerative diseases.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglia, the brain's innate immune cells, contribute to neuroinflammation and protein aggregation spread via extracellular vesicles (EVs).
- Selenoprotein P (Sepp1) is implicated as a potential regulator of microglial EV secretion.
Purpose of the Study:
- To investigate the impact of Sepp1 silencing on microglial transcriptomics and elucidate its regulatory mechanism in EV secretion.
- To validate the effect of Sepp1 on EV secretion in a mouse model of Alzheimer's disease (APPNL-G-F knockin mice).
Main Methods:
- Single-vesicle flow cytometry and super-resolution microscopy were used to quantify EV secretion and CD63 loading.
- Transcriptomic analysis of microglia following Sepp1 silencing.
- In vitro studies involving astrocytes and neurons, and in vivo studies in APPNL-G-F mice.
Main Results:
- Sepp1 silencing significantly reduced EV secretion and CD63 loading in BV-2 microglia.
- Sepp1 deficiency led to downregulation of EV biogenesis machinery, increased lysosomal activity, and altered lipid metabolism.
- In vivo, Sepp1 silencing decreased EV secretion from microglia in APPNL-G-F mouse brains.
Conclusions:
- Sepp1 plays a crucial role in regulating microglial EV secretion.
- Targeting Sepp1 may offer a therapeutic strategy to mitigate the spread of neurodegenerative pathologies mediated by microglial EVs.
Related Concept Videos
Intralumenal Vesicles and Multivesicular Bodies
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
ER Retrieval Pathway
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...

